Kaput, K., 		Lyon, E., & 		Schauer, i.
(2025).
 Acipimox in Type 1 Diabetes: fatty acids as a potential, but challenging, therapeutic target.
<em>Medical Research Archives, 12</em>(12).
doi:10.18103/mra.v12i12.6170